Drug Ad Crackdown Demonstrates Admin's Aggressive Stance

By Nikki Reeves, Heather Banuelos and Gillian Russell ( October 6, 2025, 7:10 PM EDT) -- On Sept. 9, the U.S. Food and Drug Administration issued a press release announcing "sweeping reforms to rein in misleading direct-to-consumer pharmaceutical advertisements,"[1] while simultaneously sending a templated letter[2] to thousands of pharmaceutical companies demanding promotional compliance and over 100 cease-and-desist letters to companies for deceptive advertising related to specific products....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login